Peripheral arterial disease: Lack of awareness in Canada

Canadian Journal of Cardiology

Volumn 25, Issue 1, 2009, Pages 39-45

  Lovell, Marge ^a   Harris, Kenneth ^b   Forbes, Thomas ^c   Twillman, Gwen ^d   Abramson, Beth ^e   Criqui, Michael H ^f   Schroeder, Paul ^g   Mohler III, Emile R ^h   Hirsch, Allan T ⁱ  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b WESTERN UNIVERSITY   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d Peripheral Arterial Disease Coalition   (United States)

^e ST MICHAEL'S HOSPITAL   (Canada)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g Abt SRBI Inc   (United States)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Cardiovascular disease; Claudication; Myocardial infarction; Peripheral arterial disease; Prevention; Risk factors

Indexed keywords

ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; ATTITUDE TO HEALTH; AWARENESS; CANADA; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; DIABETES MELLITUS; EDUCATIONAL STATUS; HEALTH SURVEY; HYPERTENSION; INTERVIEW; LEG PAIN; LOWEST INCOME GROUP; POPULATION RESEARCH; PREVALENCE; PUBLIC HEALTH; RISK ASSESSMENT; RISK FACTOR;

EID: 60849131756     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0828-282X(09)70021-2     Document Type: Article

References (41)

1. Rosamond W, Flegal K, Furie K, et al; for the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2008 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008;117:e25-e146.
2. Criqui MH. Peripheral arterial disease - epidemiological aspects. Vasc Med 2001;6(Suppl 1):3-7.
3. Diehm C, Schuster A, Allemberg R, et al. High prevalence of peripheral arterial disease and comorbidity in 6880 primary care patients: Cross sectional study. Atherosclerosis 2004;172:95-105.
4. Meru AV, Mittra S, Thyagarajan B, Chugh A. Intermittent claudication: An overview. Atherosclerosis 2006;187:221-37.
5. Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992;326:381-6.
6. Steg G, Bhatt DL, Wilson PWF, et al; for the REACH Registry Investigators. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 2007;297:1197-206.
7. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: Results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004;110:738-43.
8. Allison MA, Ho E, Denenberg JO, et al. Ethnic specific prevalence of peripheral arterial disease in the United States. Am J Prev Med 2007;32:328-33.
9. Hirsch AT, Criqui MH, Treat-Jacobsen D, et al. Peripheral arterial disease detection, awareness and treatment in primary care. JAMA 2001;286:1317-24.
10. Lange S, Diehm S, Darius H, et al. High prevalence of peripheral arterial disease and low treatment rates in elderly primary care patients with diabetes. Exp Clin Endocrinol Diabetes 2004;112:566-73.
11. Fowkes FG, Housley E, Cawood EH, Macintyre CC, Ruckley CV, Precott RJ. Edinburgh Artery Study: Prevalence of asympomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991:20:384-92.
12. Abramson BL, Huckell V, Anand S, et al; Canadian Cardiovascular Society Consensus Conference: Peripheral arterial disease - executive summary. Can J Cardiol 2005;21:997-1006.
13. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): Executive summary - a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines. J Am Coll Cardiol 2006;47:1239-312.
14. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-421.
15. Chobanian AV, Bakris GL, Black HR, et al; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. JAMA 2003;289:2560-72.
16. McAlister FA, Wooltorton E, Campbell NRC; for The Canadian Hypertension Education Program. The Canadian Hypertension Education Program (CHEP) recommendations: Launching a new series. CMAJ 2005;173:508-9.
17. Hirsch AT, Murphy TP, Lovell MB, et al; for the Peripheral Arterial Disease Coalition. Gaps in public knowledge of peripheral arterial disease: The first national PAD public awareness survey. Circulation 2007;116:2086-94.
18. Brick JM, Waksberg J, Kulp D, Starer A. Bias in list-assisted telephone samples. Public Opin Q 1995;59:218-35.
19. Health Canada Statistics. Population. (Version current at November 18, 2008).
20. C-M Chow, JY Chu, JV Tu, GW Moe. Lack of awareness of heart disease and stroke among Chinese Canadians: Results of a pilot study of the Chinese Canadian Cardiovascular Health Project. Can J Cardiol 2008,24:623-8.
21. Petrella RJ, Campbell NR. Awareness and misconception of hypertension in Canada: Results of a national survey. Can J Cardiol 2005;21:589-93.
22. Clement DL, Belch JJF. Vascular disease public education: The mandate is international. Int Angiol 2004;23:1-4.
23. Ismal HM, Jackosn K, Smith D. Diagnosis and treatment of peripheral arterial disease compared with other atherosclerotic vascular diseases in a university primary care clinic. J Investig Med 2006;54:255-61.
24. Belch JJF, Topol EJ, Agnelli G, et al. Critical issues in peripheral arterial disease detection and management: A call to action. Arch Int Med 2003;163:884-92.
25. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: Epidemiology, pathophysiology, and management. JAMA 2002;287:2570-81.
26. Public Health Agency of Canada. Reducing Health Disparities - Roles of the Health Sector: Recommended Policy Directions and Activities (Version current at November 18, 2008).
27. Wong B, Yung BM, Chow CM, Boswell KM, Abramson BL. Increasing internet use among cardiovascular patients: New opportunities for heart health promotion. Can J Cardiol 2005;21:349-54.
28. Chan RH, Kwan K, Abramson BL. Complimentary alternative medicine use in patients with CV disease: A breakdown in patient-physician communication. Program and Abstracts of the American Heart Association Scientific Seminar. Dallas, November 13 to 16, 2005. (Abst 2520)
29. Burt VL, Cutler JA, Hoggins M, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population: Data from the health examination surveys, 1960 to 1991. Hypertension 1995;26:60-9.
30. Muntner P, DeSalvo KB, Wildman RP, Raggi P, He J, Whelton PK. Trends in the prevalence, awareness, treatment and control of cardiovascular disease risk factors among noninstitutionalized patients with a history of myocardial infarction and stroke. Am J Epidemiol 2006;163:913-20.
31. Mosca L, Ferris A, Fabunmi R, Robertson RM. Tracking women's awareness of heart disease: An American Heart Association national study. Circulation 2004;109:573-9.
32. Hirsch AT, Gloviczki P, Drooz A, Lovell M, Creager MA; on behalf of the Trustees of the Vascular Disease Foundation. The Mandate for Creation of a National PAD Public Awareness Program: An opportunity to improve cardiovascular health. J Vasc Surg 2004;39:474-81.
33. Potvin L, Richard L, Edwards AC. Knowledge of cardiovascular disease risk factors among the Canadian population: Relationships with indicators of socioeconomic status. CMAJ 2000;162(9 Suppl):S5-11.
34. Janz N, Becker MH. The health belief model: A decade later. Health Educ Q 1984;11:1-47.
35. Onysko J, Maxwell C, Eliaszaw M, Zhang JH, Johansen H, Campbell NR. Large increases in hypertension diagnosis and treatment in Canada after a healthcare professional program. Hypertension 2006;48:853-60.
36. Peripheral Arterial Disease Coalition. (Version current at November 18, 2008).
37. National Heart, Lung, and Blood Institute. Stay in Circulation Campaign. (Version current at November 18, 2008).
38. Kundhal MD, Chin SL, Harrison L, et al. Patterns of medical therapy in patients with peripheral arterial disease in a tertiary care centre in Canada. Can J Cardiol 2007;23:357-61.
39. Al-Omran M, Lindsay TF, Major J, Jawas A, Leiter LA, Verma S; Systematic Assessment of Vascular Risk Investigators. Perceptions of Canadian vascular surgeons toward pharmacological risk reduction in patients with peripheral arterial disease. Ann Vasc Surg 2006;20:555-63.
40. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; on behalf of the TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007;45(1 Suppl):S5-S67
41. Tolonen H, Helakorpi S, Talala K, Helasoja V, Martelin T, Prattala R. 25-year trends and socio-demographic differences in response rates: Finnish adult health behaviour survey. Eur J Epidemiol 2006;21:409-15.